Literature DB >> 25185171

A plan of attack for deadly cancers.

.   

Abstract

The NCI has released strategic plans for making progress against two of the nation's deadliest cancers-lung and pancreatic cancers-in response to the Recalcitrant Cancer Research Act, which was passed by Congress in 2012. ©2014 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2014        PMID： 25185171     DOI： 10.1158/2159-8290.CD-NB2014-114

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  5 in total

1.  Small cell lung cancer: updates and new concepts.

Authors:  Peter Ujhazy; O Wolf Lindwasser
Journal:  Transl Lung Cancer Res       Date:  2018-02

2.  Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.

Authors:  Patrick Kellish; Daniil Shabashvili; Masmudur M Rahman; Akbar Nawab; Maria V Guijarro; Min Zhang; Chunxia Cao; Nissin Moussatche; Theresa Boyle; Scott Antonia; Mary Reinhard; Connor Hartzell; Michael Jantz; Hiren J Mehta; Grant McFadden; Frederic J Kaye; Maria Zajac-Kaye
Journal:  J Clin Invest       Date:  2019-04-29       Impact factor: 14.808

3.  EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer.

Authors:  Victoria Foy; Colin R Lindsay; Alexandra Carmel; Fabiola Fernandez-Gutierrez; Matthew G Krebs; Lynsey Priest; Mathew Carter; Harry J M Groen; T Jeroen N Hiltermann; Antonella de Luca; Francoise Farace; Benjamin Besse; Leon Terstappen; Elisabetta Rossi; Alessandro Morabito; Francesco Perrone; Andrew Renehan; Corinne Faivre-Finn; Nicola Normanno; Caroline Dive; Fiona Blackhall; Stefan Michiels
Journal:  Transl Lung Cancer Res       Date:  2021-04

4.  Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients.

Authors:  Cong Zhao; Zhiyun Zhang; Xingsheng Hu; Lina Zhang; Yanxia Liu; Ying Wang; Yi Guo; Tongmei Zhang; Weiying Li; Baolan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

5.  Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.

Authors:  Shuang Zhang; Shuang Li; Ying Cheng
Journal:  Thorac Cancer       Date:  2020-10-15       Impact factor: 3.500
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.